Li Ning Li
Direttore/Membro del Consiglio presso HaploX Investment Holding Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Yuk Lam Lo | M | 76 |
HaploX Investment Holding Ltd.
 HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | - |
| Yan Zhang | F | 51 |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | - |
| Qiu Qin Lou | M | 44 |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | - |
| Jia Xiang | M | 42 |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | - |
| Hoi Ting Wong | F | 36 |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | 1 anni |
| Ying Liu | F | 55 |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | 1 anni |
| Hao Zhang | M | 46 |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | 1 anni |
| Xiao Ni Zhang | F | 37 |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | 3 anni |
| Fei Fei Zhou | F | 44 |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | - |
| Chao Lu | M | 39 |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | 2 anni |
| Jia Hua Li | M | 30 |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Rebecca Price | F | - |
University of Cardiff
| 4 anni |
| Oliver Bazin | M | - |
University of Cardiff
| 4 anni |
| Chun Bo Zhang | M | 47 |
China Pharmaceutical University
| 4 anni |
| Xiao Lin Liu | F | 47 |
China Pharmaceutical University
| 4 anni |
| Richard Pearce | M | - |
University of Cardiff
| 3 anni |
| Naveen Samant | M | 46 |
University of Cardiff
| 3 anni |
| Sing Chia Tan | F | 35 |
University of Cardiff
| 4 anni |
| Ju Biao Fu | M | 53 |
China Pharmaceutical University
| 3 anni |
| Jing Sun | F | 47 |
China Pharmaceutical University
| 7 anni |
| Victoria Marsh Durban | M | - |
University of Cardiff
| 3 anni |
| Ang Zhou | M | 59 |
China Pharmaceutical University
| 4 anni |
| Yanbin Yin | M | 56 |
China Pharmaceutical University
| 4 anni |
| Qing Ping Li | M | 46 |
China Pharmaceutical University
| 4 anni |
| Li Sheng | M | 45 |
China Pharmaceutical University
| 4 anni |
| Matt Jackson | M | - |
University of Cardiff
| 3 anni |
| John Stevens | M | - |
University of Cardiff
| 4 anni |
| Jiao Huiliang | M | 52 |
China Pharmaceutical University
| 3 anni |
| Ali Masmali | M | - |
University of Cardiff
| 4 anni |
| Yang Chao | M | 52 |
China Pharmaceutical University
| 4 anni |
| Hai Ye | M | 48 |
China Pharmaceutical University
| 4 anni |
| Joey Robinson | M | - |
University of Cardiff
| 3 anni |
| Bingyao Chen | M | 50 |
China Pharmaceutical University
| 4 anni |
| Qun Zhao | M | 49 |
China Pharmaceutical University
| 4 anni |
| Xiao Qing Mao | M | 51 |
China Pharmaceutical University
| 4 anni |
| Anish Bansal | M | 39 |
University of Cardiff
| 4 anni |
| Li Sheng | M | 44 |
China Pharmaceutical University
| 4 anni |
| Thomas Platt | M | - |
University of Cardiff
| 4 anni |
| Xue Feng Liu | M | 48 |
China Pharmaceutical University
| 4 anni |
| Nawaf Hussain Maarifi Al-Maarifi | M | - |
University of Cardiff
| 2 anni |
| Wai Cheong Law | M | 38 |
University of Cardiff
| 3 anni |
| Yu Wen Liu | F | - |
China Pharmaceutical University
| 3 anni |
| Jiao Jiao Shen | F | 42 |
University of Cardiff
| 1 anni |
| Sheikh Naseer Hyder | M | - |
University of Cardiff
| 2 anni |
| Guang Ji Wang | M | 71 |
China Pharmaceutical University
| 16 anni |
| Jian Ping Zhou | M | 64 |
China Pharmaceutical University
| 3 anni |
| Huan Li Li | M | 42 |
University of Cardiff
| 1 anni |
| Saeed Mubarak Al-Muharrami | M | - |
University of Cardiff
| 3 anni |
| Li Jian Zhang | M | 71 |
University of Cardiff
| 3 anni |
| Xiao Quan Liu | M | 64 |
China Pharmaceutical University
| 3 anni |
| Xiao Min Yao | F | 50 |
China Pharmaceutical University
| 4 anni |
| Yan Yang | F | 40 |
China Pharmaceutical University
| 14 anni |
| Michalis Charalambous | M | - |
University of Cardiff
| 1 anni |
| Hong Bin Sun | M | 58 |
China Pharmaceutical University
| 3 anni |
| Rong Li Yuan | M | 52 |
University of Cardiff
| 3 anni |
| Xiao Ming Wu | M | 70 |
China Pharmaceutical University
| 16 anni |
| Yang Guang | M | 48 |
China Pharmaceutical University
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Cina | 25 | 43.86% |
| Regno Unito | 21 | 36.84% |
| Isole Cayman | 11 | 19.30% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Li Ning Li
- Contatti personali
